Search Results - liver+disease

4 Results Sort By:
Quercetin as substrate for antiviral treatment against Hepatitis C virus infection (UCLA Case No. 2023-003)
UCLA researchers in the Department of Pathology and Hematology have developed a novel antiviral treatment for Hepatitis C virus based on the metabolic modulating properties of dietary compound Quercetin. BACKGROUND: Hepatitis C virus (HCV) is responsible for 180 million infections worldwide and over 12,000 deaths in the U.S. each year. Despite most...
Published: 5/16/2024   |   Inventor(s): Nu Lu
Keywords(s): antivirals, hepatitis, immune metabolism, Inflammation, liver disease
Category(s): Therapeutics > Infectious Diseases, Therapeutics > Inflammation And Inflammatory Diseases
Real-time RT-PCR Assay For Detection and Quantification of Hepatitis D Virus Infection
CDC scientists have developed a one-step TaqMan quantitative/real-time reverse transcription-polymerase chain reaction (qRT-PCR) assay for detecting hepatitis D virus (HDV) RNA. Additionally, a quantifiable synthetic RNA control to determine viral load has been created. HDV is an operatively defective virus that requires hepatitis B virus (HBV) surface...
Published: 10/28/2024   |   Inventor(s): Tonya Mixson-Hayden, Saleem Kamili, Maja Kodani
Keywords(s): assay, CDC Docket Import, CDC Docket Import CDC Prosecuting, cirrhosis, D, DA4BXX, DA4XXX, DAXXXX, Detection, diagnostic, Diagnostic assay, DXXXXX, HBV, HDV, Hepatitis, HEPATITIS B, liver, liver disease, Liver disorders, Liver-Disease, OID-NCHHSTP-DVH, PCR, QUANTITATIVE, REAL, real time, REAL-TIME, RT-PCR, viral, virus
Category(s): Collaboration Sought > Licensing, Application > Diagnostics, TherapeuticArea > Infectious Disease
Antibodies Targeting CB1/AT1R or CB1/A2aR Heteromers to Treat Liver Fibrosis
Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/9y5gxRj67BLK
Published: 10/23/2024   |   Inventor(s): Lakshmi Arehole Devi, Raphael Rozenfeld
Keywords(s): Fibrosis, Liver Disease
Category(s): Therapeutic
A Method to Treat Alzheimer’s, Heart and Liver Diseases
Technology Description This technology describes a process for the preparation of the tripeptide glutathione or its precursors to be delivered to the mitochondria for treating age-related conditions, toxicologic exposures, neurodegeneration, heart disease, and liver damage. More specifically, glutathione precursors and derivatives are coupled to a lipophilic...
Published: 5/26/2021   |   Inventor(s): Tory Hagen, Joseph Beckman, Pamela Beilby
Keywords(s): ALS, Alzheimer's, Antioxidant, Cancer, Liver disease, Medical Science & Technologies, Mitochondria, Neurodegenerative disease
Category(s): Biological Materials, Chemical, Diagnostics, Research Tools, Therapeutics